| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.01B | -6.7% |
| Cost of Revenue | $1.55B | -8.8% |
| Gross Profit | $1.46B | -4.3% |
| R&D Expense | $174.0M | -13.0% |
| SG&A Expense | $380.0M | +12.8% |
| Operating Income | $880.0M | -11.3% |
| Pre-tax Income | $804.0M | -10.4% |
| Income Tax | $181.0M | +9.0% |
| Net Income | $623.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.50B | +91.4% |
| Accounts Receivable | $333.0M | -7.5% |
| Inventory | $316.0M | +0.3% |
| Current Assets | $2.23B | +45.2% |
| Total Assets | $6.08B | +14.0% |
| Current Liabilities | $460.0M | -9.1% |
| Long-term Debt | $2.91B | +20.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $836.0M | +4.4% |
| Capital Expenditures | $175.0M | +22.4% |
| Investing Cash Flow | -$184.0M | -25.2% |
| Financing Cash Flow | $57.0M | +113.3% |
| Free Cash Flow | $661.0M | +0.5% |
| -14.8% |
| EPS (Basic) | $7.42 | -11.7% |
| EPS (Diluted) | $7.33 | -11.8% |
| Total Liabilities |
| $4.21B |
| +14.4% |
| Stockholders' Equity | $1.87B | +13.1% |